PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Send a file File manager PDF Toolbox Search Help Contact


Pharmaceutical Drugs Global Market Report 2018 .pdf



Original filename: Pharmaceutical Drugs Global Market Report 2018.pdf
Author: TBRC-33

This PDF 1.5 document has been generated by Microsoft® Word 2016, and has been sent on pdf-archive.com on 10/08/2018 at 12:10, from IP address 162.243.x.x. The current document download page has been viewed 54 times.
File size: 1.4 MB (12 pages).
Privacy: public file



Download original PDF file








Document preview


Pharmaceutical Drugs
Global Market Report 2018
Including: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs;
Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases
Drugs; Gastrointestinal Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology Drugs
Covering: Novartis AG, Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer Inc., Gilead Sciences Inc.

Feb 2018

Reasons to Purchase
• Outperform competitors using accurate up to date demand-side dynamics
information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the
drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high
quality data and analysis
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 3-5
working days of order.

Scope
Markets Covered: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology
Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs;
Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal Drugs; Hematology
Drugs; Dermatology Drugs; Ophthalmology Drugs.
Companies Mentioned: Novartis AG, Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer Inc.,
Gilead Sciences Inc.
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and
Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita,
Pharmaceutical Drugs Indicators Comparison.
Data segmentations: Country and regional historic and forecast data, market share of
competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end
notes.

Pharmaceutical Drugs Market
Characteristics
The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent
diseases. Pharmaceutical companies produce both generic and branded drugs.
Pharmaceutical drugs are subjected to various laws and regulations that deal with
patenting, testing, safety, efficacy and marketing.
Pharmaceutical companies produce pharmaceutical drugs made from active
pharmaceutical ingredients (API) and excipients.
Pharmaceutical preparations are drugs intended for human or veterinary use
presented in their finished dosage form. Companies engaged in pharmaceutical
preparations are involved in drug discovery and development, manufacturing, drug
processing and sales and marketing of drugs for human or veterinary use. Tablets,
ampoules, capsules, ointments and medicinal powders and solutions are the
various pharmaceutical preparations produced by pharmaceutical companies.
The pharmaceutical drugs market is segmented as follows:
Musculoskeletal Disorders Drugs market comprises companies that
Cardiovascular Drugs market covers the drugs used to treat conditions that affect
the heart or
Oncology Drugs prevent the growth of malignant tumors by affecting the process
of cell division or by
Anti-infective Drugs are used to treat infectious diseases caused by several
pathogenic organisms such as
Metabolic Disorder Drugs market covers medications that are used in the

Central Nervous System Drugs market includes drugs that are used for the
treatment of a
Genito-urinary Drugs market covers drugs that are used in the treatment of
diseases such as
Respiratory Drugs market covers drugs that are used in the treatment of a wide
range of
Gastrointestinal Drugs market covers medicines used for the treatment of
ulcerative colitis, diverticular disease, perianal infections, and
Hematology Drugs market offers drugs, blood and blood products that are used
for the
Dermatology Drugs market includes medications that are used for the treatment
of skin conditions such as
Ophthalmology Drugs market covers drugs that are used in

In this report market value is defined as the revenues organizations earn by
selling their goods and services within the specified market, based on the price at
which they sell. Only goods and services traded between entities are included.
The revenues for a specified geography are consumption values – that is, they are
revenues generated by organizations in the specified geography within the
specified market, irrespective of where they are produced.

Pharmaceutical Drugs Market
Historic Growth
The global pharmaceutical drugs market grew from $X billion in 2013 to $X billion
in 2017 at a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global
pharmaceutical drugs market during 2013 – 2017.

Drivers of the Market:

Restraints on the Market:

Pharmaceutical Drugs Market
Forecast Growth
The global pharmaceutical drugs market is expected to grow from $XX billion in
2017 to $1,170 billion in 2021 at a compound annual growth rate (CAGR) of XX%.
The chart and table below shows the year-on-year growth of the global
pharmaceutical drugs market during 2017 - 2021.

Drivers of the Market:

Restraints on the Market:

Pharmaceutical Drugs Market
Segmentation
The chart and table below shows the split of the pharmaceutical drugs market in
2017.

The total market value for pharmaceutical drugs was $X billion in 2017. The markets
that are covered include Musculoskeletal Disorders Drugs; Cardiovascular Drugs;
Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous
System Drugs; Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal
Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology Drugs.
Musculoskeletal Disorders Drugs was the X largest segment in the pharmaceutical
drugs market with X% share of the market. The market value for the
musculoskeletal disorders drugs was $X billion in 2017.
Cardiovascular Drugs made up around X% share of the market. The market value
for the cardiovascular drugs was $X billion in 2017.

Pharmaceutical Drugs Market
Regional And Country Analysis
The Asia Pacific was the largest region in the pharmaceutical drugs market in 2017,
pharmaceutical drugs for $X billion or X% market share.
North America was the x largest region pharmaceutical drugs for $X billion or X%
market share.
Western Europe was the x largest region pharmaceutical drugs for $X billion or X%
market share.

Pharmaceutical Drugs Market
Competitive Landscape
The leading competitors in the global pharmaceutical drugs market are Novartis
AG, Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer Inc., Gilead Sciences Inc.
The chart and table below displays the percentage market share of the top players
in the pharmaceutical drugs market industry.

Novartis AG generated revenues of $XX billion for the financial year 2016, an XX%
decrease from the previous year.
Sanofi S.A. generated revenues of $XX billion for the financial year 2016, an XX%
decrease from the previous year.
F. Hoffmann-La Roche Ltd. generated revenues of $XX billion for the financial year
2016, an XX% increase from the previous year.
Pfizer Inc. generated revenues of $XX billion for the financial year 2016, an XX%
increase from the previous year.

Gilead Sciences, Inc. generated revenues of $XX billion for the financial year 2016,
an XX% decrease from the previous year.
Johnson & Johnson generated revenues of $XX billion for the financial year 2016,
an XX% increase from the previous year.
GlaxosmithKline Plc. generated revenues of $XX billion for the financial year 2016,
an XX% increase from the previous year.
Bayer AG generated revenues of $XX billion for the financial year 2016, an XX%
decrease from the previous year.
Teva Pharmaceuticals generated revenues of $XX billion for the financial year
2016, an XX% increase from the previous year.
Merck & Co. generated revenues of $XX billion for the financial year 2016, an XX%
decrease from the previous year.Company Profile
Novartis AG
Overview
Novartis AG was the largest competitor in the pharmaceutical drugs market
in 2017 with a XX% share of the market. Novartis is a multinational
pharmaceutical company that develops, manufacture and markets
healthcare products. The company was founded in 1970 and is
headquartered in Basel, Switzerland.
Products and Services
The company operates through the following divisions –
The Innovative Medicines division focuses on ophthalmology,
neuroscience, immunology and
The Alcon division focuses on the
The Sandoz division focuses on biopharmaceuticals,

Strategy
Novartis’ growth strategy is to focus on strengthening its ophthalmology
pipeline through acquisitions. In December 2016, the company acquired
pharmaceutical company Encore Vision, Inc. that develops treatment for
presbyopia, an ophthalmologic disorder. In addition, Novartis is focusing on
licensing new products to
Financial Performance
Novartis generated revenues of $XX billion for the financial year 2016, a
XX% decrease from the previous year. The company had a market

Sanofi S.A
Overview
Products and Services
Strategy
Financial Performance

F. Hoffmann-La Roche Ltd.
Overview
Products and Services
Strategy
Financial Performance

Pfizer Inc.
Overview
Products and Services
Strategy
Financial Performance

Gilead Sciences Inc.
Overview
Products and Services
Strategy
Financial Performance



Related keywords